-
Comparative Cardiovascular Safety of Romosozumab and Denosumab in Osteoporosis Treatment: A Multinational Real-World Cohort Study
Sep 9, 2025, 16:22 PM -
Optimizing Patient-Reported Outcomes in German HTA: Addressing Key Challenges and Methodological Requirements
Sep 9, 2025, 16:22 PM -
Three Systems, One Market? A Comparative Analysis of Medical Device Reimbursement in Germany, Austria, and Switzerland
Sep 9, 2025, 16:22 PM -
Real-World Utilization Pattern of GLP-1 Receptor Agonists in German Outpatient Care
Sep 9, 2025, 16:22 PM -
Air Pollution Signals and National Demand for Asthma Medication in Brazil Between 2018-2023: Should It Be Considered a Public-Health Concern?
Sep 9, 2025, 16:22 PM -
Impact of Disease Progression on Healthcare Resource Utilization and Quality of Life in Patients With Hypertrophic Cardiomyopathy: A Real-World Cross-Sectional Survey
Sep 9, 2025, 16:22 PM -
Generation of Synthetic Patient Data to Overcome Machine Learning Limitations in Healthcare Research: A Systematic Review of Methods, Performance, and Use Cases
Sep 9, 2025, 16:22 PM -
Unlocking the Value of RSV Adult Vaccination With Adjuvanted RSVpreF3 Vaccine in Germany: A Return on Investment Analysis Using an Integrated Actuarial-Macroeconomic Model
Sep 9, 2025, 16:22 PM -
Development of a Discrete Choice Experiment Survey to Assess Patient Preferences for Treatment of Metastatic Breast Cancer
Sep 9, 2025, 16:22 PM -
HTA for Obesity and T2DM Indications: A Review and Recommendations for Future Appraisals
Sep 9, 2025, 16:22 PM -
What Matters Most to Women in Breast Biopsy? A Discrete Choice Experiment in Italy
Sep 9, 2025, 16:22 PM -
Stakeholder Mapping and Policy Assessment of Rare Diseases in Southeast Asia
Sep 9, 2025, 16:22 PM -
Evaluating GenAI for HTA Analogue Analysis: Identifying Rare Disease Approvals With Surrogate Endpoints and Single-Arm Trials
Sep 9, 2025, 16:22 PM -
A Strategic National Framework for Managed Entry Agreements to Access Innovative and Breakthrough Medications in Saudi Arabia
Sep 9, 2025, 16:22 PM -
The Impact of Treatment Compliance on Healthcare Resource Utilization Amongst Kidney Transplant Recipients: Results From a Real-World Survey
Sep 9, 2025, 16:22 PM -
Can Estimands Support Aligned Evidence Generation for EU HTA? Reflections on Their Role in Joint Clinical Assessments, PICO Alignment, and Beyond
Sep 9, 2025, 16:22 PM -
Understanding Heterogeneity in the Classification of Locally Advanced Cancer: Analysis of Clinical Trial Records From the Past 2 Years (2023-2025)
Sep 9, 2025, 16:22 PM -
Benefits and Challenges in the Implementation of EU HTAR for Medical Devices: Lessons Learned From the Pharmaceutical Industry
Sep 9, 2025, 16:22 PM -
Price Behavior of Originator Adalimumab After Biosimilars Entry: Evidence From the Colombian Market
Sep 9, 2025, 16:22 PM -
Comparing Robotic-Assisted Coronary Artery Bypass Grafting Using the Da Vinci Surgical System to a Nonrobotic Approach: A Systematic Literature Review and Meta-Analysis
Sep 9, 2025, 16:22 PM
